Calcilytix Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Calcilytix Therapeutics's estimated annual revenue is currently $2.3M per year.(i)
  • Calcilytix Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Calcilytix Therapeutics has 15 Employees.(i)
  • Calcilytix Therapeutics grew their employee count by 15% last year.

Calcilytix Therapeutics's People

NameTitleEmail/Phone
1
DirectorReveal Email/Phone
2
Associate Director - Drug Substance Development and ManfacturingReveal Email/Phone
3
Director, Analytical DevelopmentReveal Email/Phone
4
Senior Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Calcilytix Therapeutics?

Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is a clinical-stage biopharmaceutical company focused on developing a targeted therapy for disorders of calcium homeostasis. Our product candidate, encaleret, is an investigational orally-administered small molecule designed to specifically inhibit the calcium-sensing receptor, hypothesized to restore normal serum calcium and lower urine calcium.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M150%N/A
#2
$2.3M15-21%N/A
#3
$0.4M15-42%$156.1M
#4
$0.7M15-29%$96.4M
#5
$1.2M15N/AN/A